Cancer, being a scourge that no one can even wish on their worst enemies, creativity and entrepreneurship on how to handle or deal with it is paramount. That is why, it is good to have dreams, but something better to make those dreams a reality. Imagine the dawn of cancer freedom. One individual that has contributed a lot towards this gesture is Eric Lefkofsky.
Eric Lefkofsky, who is the co-founder and CEO of Tempus, is a man who makes this world a better one. Born in Southfield, Michigan, he has become part of the greatest entrepreneurs in the USA. With his determination and resilience not forgetting the urge to make the society a better place, he became part of Tempus and Eric on Facebook.
Tempus, which is an organization that has come up with an operating system to fight cancer, is an organization that has positively impacted a lot of lives. It is an avenue where doctors or rather physicians can interact with cancer patients on interactive detailed and machine learning platform that has been created and Eric’s lacrosse camp.
Him as the CEO, became part of this organization to ensure that ways of treating cancer are made known by research. The motivation for this idea stemmed from watching a family member undergoing treatment for this horrible disease. Therefore, his agenda became to bring new and innovative technology to the physicians who are on the front lines treating and tending to these patients and more information click here.
Asides from his association with Tempus, he has a good heart in the sense that he does well for his community. For instance, he is a trustee in other companies like the Lurie’s Children’s Hospital of Chicago. This initiative helps a lot of children in Chicago especially, those who are not very financially okay.
Entrepreneurs are persons that command respect. This is because of a lot of innovations that are responsible for a lot of changes especially, in this day and era. For instance, there’s so much that Eric Lefkofsky has done for people be it by Tempus or other charitable institutions, it is clear that he is a man who is better off in this society and what Eric knows.
Research is the pillar of the many discoveries people enjoy today and there is massive effort to get better ways of dealing with the problems people across the world face. Cancer is one of the problems that human beings have to work against and it is only through research and new methods of treatment that one can get solutions to the menace. Finding new solutions takes the effort of professionals in different capacities, who draft measures to alleviate the complex issues that have been surrounding the disease.
One of the research institutes that have made strides in this area is Seattle Genetics, an established biotechnology company that has been in the industry since 1998. Founded and led by Clay Siegall, Seattle Genetics has made effort to ensure that the research that is conducted towards curing cancer bears fruits.
Success in cancer research
The company has worked with many professionals over the years to bring to light the development of ADCETRIS, a drug that has proved to be effective in the treatment of cancer across more than 60 countries. Its approval across many countries and getting the support of professionals in high offices has allowed the company to advance its methods of coming up with new treatment for ailments.
Clay Siegall has been able to engage many experts in the industry, who also approved the drug and cited it as an effective solution that allows the treatment of cancer without necessarily using methods that require radiation. This is not the only success Clay Siegall has achieved in his career. There are several drug pipelines his company Seattle Genetics launched, all directed to solving the cancer menace and bringing to rest the problem that has been eating the lives of millions.
With the support he also received from companies like GlaxoSmithKline, Clay Siegall has managed to venture deeper into getting solutions that help in the development of better alternatives to traditional methods of dealing with complex diseases. He is a leader in the industry and he shares his knowledge through journals and articles addressing the pressing issues that have been barring the progress of the healthcare sector across the world.